Spyre Therapeutics, Inc. (SYRE)
Nasdaq: SYRE · Pharmaceutical Preparations · Waltham, MA · filing with the SEC since 2015
Filings
491 filings since 2017 beside 256 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Mar 1, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 34 days after the quarter ended. The proxy statement was last filed Apr 10, 2026.
Filings a yearinsider forms included
5556626911011652100
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 4 times in the last 36 months, the newest May 29, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Mar 6, 2025.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest Nov 18, 2024.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Jan 18, 2024.SEC letters: 23 in the last 36 months, the newest Feb 25, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 8, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Aug 25, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Jun 15, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
May 29, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
May 27, 2026
Apr 13, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
40 of 491 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.